相关实验视频

Updated: Jan 13, 2026

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

通过代谢重编程,CRISPR/Cas策略可以增强CAR T细胞的功能和持续性

Margaret R Wang¹, Wenli Mu¹, Anjie Zhen¹

¹Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; UCLA AIDS Institute and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Trends in biotechnology

|January 6, 2026

概括

克里斯普尔/卡斯基因编辑通过改善T细胞功能和持久性来增强仿真抗原受体 (CAR) T细胞疗法. 这种方法解决了T细胞耗尽和代谢功能障碍,这对于更广泛的CAR T细胞应用至关重要.

科学领域:

免疫学免疫学免疫学
基因治疗基因治疗
癌症研究癌症研究

背景情况:

化学抗原受体 (CAR) T细胞疗法对血液癌症有效,但在其他疾病中面临局限性.
随着时间的推移,T细胞的耗尽和分化会降低CAR T细胞的有效性和持久性.
基因编辑CRISPR/Cas提供了一个强大的工具来克服这些局限性.

研究的目的:

审查CRISPR/Cas用于增强CAR T细胞疗法的应用.
专注于改善CAR T细胞功能,持久性和代谢重编程的策略.
突出了解临床前CRISPR/Cas策略对临床翻译的重要性.

主要方法:

审查目前的临床前CRISPR/Cas策略.
对CAR T细胞代谢的CRISPR/Cas介导调节的分析.
检查对抗T细胞疲劳和功能障碍的方法.

主要成果:

可以利用CRISPR/Cas技术来设计具有改善代谢概况的CAR-T细胞.
基因编辑策略在增强CAR T细胞功能和延长其持久性方面表现有前途.
通过CRISPR/Cas调节T细胞代谢是提高CAR T细胞疗效的关键领域.

结论:

基因编辑CRISPR/Cas具有显著的潜力,可以改善超出血性恶性瘤的CAR T细胞疗法.
通过CRISPR/Cas准T细胞代谢对于克服疲劳和功能障碍至关重要.
对临床前CRISPR/Cas策略的进一步研究对于改进的CAR T细胞的成功临床应用至关重要.

关键词:

在CART-T中,我们可以使用CAR-T.这就是CRISPR/CasPR.疲疲疲疲疲代谢代谢代谢代谢持续性持久性

更多相关视频

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...